News
-
Comparing Eye Exams In Mobile Settings To In-Office Exams
1/29/2025
2020 On-site, a Boston-based mobile optometry company whose mission is to expand access to high-quality vision care including clinical research, has completed its observational study to assess the quality of subjective refraction, autorefraction, and keratometry measurements in a mobile eye setting.
-
ActiGraph Accelerates Clinical Trial Modernization With Transformational Acquisition Of Biofourmis Life Science Business
1/22/2025
ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an AI-driven, digital trial platform tailored for the life science industry. The combined solution will create a market-leading, unified software and data ecosystem for the modernization of clinical research throughout the drug-product lifecycle and across therapeutic areas.
-
Avance Clinical Leads As The CRO Of Choice For Early Phase Clinical Trials In Australia – Announced At Biotech Showcase 2025
1/14/2025
Wake Forest, NC, USA | Adelaide, Australia
Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce it is the CRO of choice for Early Phase clinical trials in Australia with more than 52% of market share. Avance Clinical Australia leads in the active Phase I trials, registered on clinical trial registry ANZCTR (as of 17 December 2024). More than 80% of Avance Clinical clients are US biotechs.
Book a meeting with the Avance Clinical team at Biotech Showcase.
-
Novotech Releases Report On Global Parkinson's Disease Clinical Trial Landscape
12/30/2024
Novotech, the global full-service clinical Contract Research Organization (CRO), announces the release of its report, Parkinson’s Disease: Global Clinical Trial Landscape 2024. This report provides critical insights into the trends, opportunities, and challenges in Parkinson's disease (PD) research, serving as a valuable resource for companies developing treatments for this complex neurodegenerative disorder.
-
Novotech Named A Fierce CRO Award Winner In The Excellence In Clinical Trial Management And Global Operations Categories
12/30/2024
Novotech has announced it was named a Fierce CRO Award winner by Fierce Biotech in the Clinical Trial Management and Global Operations categories.
-
Novotech Publishes Report On The Global COVID-19 Clinical Trial Landscape
12/30/2024
The global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released an in-depth report "COVID-19: Global Clinical Trial Landscape 2024."
-
OpenClinica Named Top Contender In Electronic Data Capture (EDC) Platforms By Everest Group
12/13/2024
Everest Group, a leading global research and consulting firm, named OpenClinica a Major Contender in its Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment for 2024. The inaugural assessment evaluated 20 best-in-class EDCs based on the impact created in the market and the ability to deliver products successfully. OpenClinica differentiates itself from other EDCs with its vision and capability, earning high marks in technology capability, flexibility and ease of deployment, engagement and commercial model, and customer support.
-
OpenClinica Debuts Secure, Participant-Friendly Mobile App For Direct Health Record Sharing In Clinical Research
12/13/2024
OpenClinica Share™ simplifies the sharing of real-world and complex medical data for clinical research by participants.
-
Signant Health Names Krishna Maridi, A Finance Leader With Over 25 Years Of Experience, As Chief Financial Officer
12/11/2024
Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Krishna Maridi as chief financial officer.
-
OpenClinica Acquires BuildClinical to Accelerate Patient Recruitment
12/10/2024
OpenClinica today announced its acquisition of BuildClinical, a health technology company that helps researchers and patients find each other faster. BuildClinical uses advanced data-driven strategies to engage and enroll the ideal clinical trial population needed for a given study. Since its founding in 2020, BuildClinical has successfully enrolled more than 50,000 participants in clinical research studies, while simultaneously accelerating enrollment timelines and reducing participant engagement costs.